Developing herd immunity without pharma interventions may have detrimental consequences: Choubey Read more
Indian pharma industry will be among the first to develop and supply low cost vaccines for COVID-19: Gowda Read more
Sorrento gets US FDA nod for Phase 1 clinical trial of neutralising antibody in COVID-19 patients Read more